Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma

British Journal of Cancer

Volumn 77, Issue 1, 1998, Pages 92-97

  Ishikawa, T ^a   Furihata, M ^a   Ohtsuki, Y ^a   Murakami, H ^a   Inoue, A ^a   Ogoshi, S ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Cyclin D1; Immunohistochemistry; Prognosis; Retinoblastoma

Indexed keywords

CYCLIN D1; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CELL NUCLEUS; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

EID: 0031964608     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.14     Document Type: Article

References (38)

1. Adélaide J, Monges G, Dérdérian C, Seitz J-F and Birnbaum D (1995) Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br J Cancer 71: 64-68
2. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA and Sutherland RL (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133
3. Cong J, Ardelt B, Traganos F and Darzynkiewicz Z (1994) Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res 54: 4285-4288
4. Cordon-Cardo C (1995) Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 147: 545-560
5. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato JY and Livingston DM (1993) Functional interaction of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487-497
6. Fahn H-J, Wang L-S, Huang B-S, Huang M-H and Chien K-Y (1994) Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus. Ann Thorac Surg 57: 677-681
7. Furihata M, Ohtsuki Y, Ogoshi S, Takahashi A, Tamiya T and Ogata T (1993) Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer 54: 226-230
8. Furihata M, Ishikawa T, Inoue A, Yoshikawa C, Sonobe H, Ohtsuki Y, Araki K and Ogoshi S (1996) Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2: 1781-1785
9. Geradts J, Hu SX, Lincoln CE, Benedict WF and Xu H-J (1994) Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-Rb antibodies. Int J Cancer 58: 161-167
10. Gillett C, Fantl V, Smith R, Fisher C Bartek J, Dickson C, Barnes D and Peters G (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54: 1812-1817
11. Hermanek P, Sobin LH (eds) (1992) UICC TNM classification of malignant tumors. 4th edn, 2nd revision. Springer Verlag: Berlin
12. Hunter T and Pines J (1991) Cyclins and cancer. A review. Cell 66: 1071-1074
13. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J and Cardesa A (1994) PRAD-1/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54: 4813-4817
14. Jiang W, Zhang Y-J, Kahn SM, Hollstein MC, Santella RM, Lu SH, Harris CC, Montesano R and Weinstein IB (1993) Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 90: 9026-9030.
15. Kato H, Tachimori Y, Watanabe H, Iizuka T, Terui S, Itabashi M and Hirota T (1991) Lymph node metastasis in thoracic esophageal carcinoma. J Surg Oncol 48: 106-111
16. Kato H, Tachimori Y, Watanabe H and Iizuka T (1993) Evaluation of the new (1987) TNM classification for thoracic esophageal tumors. Int J Cancer 53: 220-223
17. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert H J and Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54: 380-385
18. Kitagawa Y, Ueda M, Ando N, Shinozawa Y, Shimizu N and Abe O (1991) Significance of int 2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res 51: 1504-1508
19. Lipponen PK, Liukkonen TJO (1995) Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer. J Cancer Res Clin Oncol 121: 44-50
20. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ and Kato JY (1994) D type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14: 2066-2076
21. McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, Henry JA, Angus B, Lennard TWJ and Horne CHW (1995) Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 11: 885-891
22. Michalides R, van Veelen N, Hart A, Loftus B, Wienjens E and Balm A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978
23. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM and Arnold A (1991) A novel cyclin encoded by BCL1-linked candidate oncogene. Nature 350: 512-515
24. Müller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M and Strauss M (1994) Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91: 2945-2949
25. Naitoh H, Shibata J, Kawaguchi A, Kodama M and Hatlori T (1995) Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 146: 1161-1169
26. Pagano M, Pepperkok R, Verde F, Ansorge W and Draetta G (1992) Cyclin A is required at two points in the human cell cycle. EMBO J 11: 961-971
27. Pines J and Hunter T (1994) Cyclins and cancer II: cyclin D1 and CDK inhibilors come of age. Cell 79: 573-582
28. Sherr CJ (1993) Mammalian G1 cyclins. Cell 73: 1059-1065
29. 110RB) in osteosarcomas and synovial sarcomas. Oncogene Res 1: 205-214
30. Shimaya K, Shiozaki H, Inoue M, Thahara H, Monden T, Shimano T and Mori T (1993) Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Virchows Arch A Pathol Anat Histol 422: 271-276
31. Shinozaki H, Ozawa S, Ando N, Tsuruta H, Terada M, Ueda M and Kitajima M (1996) Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res 2: 1155-1161
32. Trudel M, Mulligan L, Cavenee W, Margolese R, Cote J and Gariepy G (1992) Retinoblastoma and p53 gene product expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation. Hum Pathol 23: 1388-1394
33. Tsuruta H, Sakamoto H, Onda M and Terada M (1993) Amplification and overexpression of EXP1 and EXP2/cyclin D1 genes in human esophageal carcinomas. Biochem Biophys Res Commun 196: 1529-1536
34. Weinberg RT (1991) Tumor suppressor genes. Science 254: 1138-1146
35. Withers D, Harvey R, Faust J, Melnyk O, Carey K and Meeker T (1991) Characterization of a candidate bcl-1 gene. Mol Cell Biol 11: 4846-4853
36. Xu HJ, Hu SX and Benedict WF (1991) Lack of nuclear RB protein staining in G0/G1 cells: correlation to changes in total RB protein level. Oncogene 6: 1139-1146
37. Xu HJ, Hu SX, Hashimoto T, Takahashi R and Benedict WF (1989) The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. Oncogene 4: 807-812
38. Zang YG, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM and Weinstein IB (1993) Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196: 1010-1016